Immunomodulatory effects of galectin-1 in patients with chronic lymphocytic leukemia

Galectin-1 (Gal-1) has been implicated in the progression of chronic lymphocytic leukemia (CLL) but also the development of immunodeficiency, which commonly accompany this malignancy. In this in vitro study, we investigated the effects of Gal-1 inhibition in the sera of immunocompromised CLL patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostic, Milos, Dzopalic, Tanja, Marjanovic, Goran, Urosevic, Ivana, Milosevic, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Clinical Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056350/
https://www.ncbi.nlm.nih.gov/pubmed/33897284
http://dx.doi.org/10.5114/ceji.2021.105246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056350/
https://www.ncbi.nlm.nih.gov/pubmed/33897284
http://dx.doi.org/10.5114/ceji.2021.105246

Ejemplares similares